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ABSTRACT Allergic asthma is common airway disease that is characterized in part by enhanced airway
constriction in response to nonspecific stimuli. Genome-wide association studies have identified multiple
loci associated with asthma risk in humans, but these studies have not accounted for gene–environment
interactions, which are thought to be important factors in asthma. To identify quantitative trait loci (QTL) that
regulate responses to a common human allergen, we applied a house dust mite mouse (HDM) model of
allergic airway disease (AAD) to 146 incipient lines of the Collaborative Cross (CC) and the CC founder
strains. We employed a longitudinal study design in which mice were phenotyped for response to the
bronchoconstrictor methacholine both before and after HDM sensitization and challenge using whole body
plethysmography (WBP). There was significant variation in methacholine responsiveness due to both strain
and HDM treatment, as reflected by changes in the WBP parameter enhanced pause. We also found that
distinct QTL regulate baseline [chromosome (Chr) 18] and post-HDM (Chr 19) methacholine responsiveness
and that post-HDM airway responsiveness was correlated with other features of AAD. Finally, using invasive
measurements of airway mechanics, we tested whether the Chr 19 QTL affects lung resistance per se using
C57BL/6J mice and a consomic strain but found that QTL haplotype did not affect lung resistance. We
conclude that aspects of baseline and allergen-induced methacholine responsiveness are associated with
genetic variation, and that robust detection of airway resistance QTL in genetically diverse mice will be
facilitated by direct measurement of airway mechanics.
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Allergic asthma is a common disease that affects 10–15% of the
population and causes substantial decrements in quality of life and
productivity (Mannino et al. 1998, 2002). The disease is characterized
by elevated IgE, airway inflammation, mucus hyper-secretion, and air-
way hyper-responsiveness (Busse and Lemanske 2001). Asthma is
thought to result from a combination of both genetic and environmen-
tal risk factors (von Mutius 2009; Ober and Vercelli 2012; Rava et al.
2015) and significant progress has been made toward the identification
of both types of risk factors, particularly genetic risk factors as of late.
Genome-wide association studies (GWAS) have identified at least
20 distinct loci with asthma in multiple study populations (Welter
et al. 2014; Bønnelykke et al. 2015; Ortiz and Barnes 2015). Still, the
percent of heritable and total disease risk explained remains low
(Moffatt et al. 2010), and these studies have not accounted for gene–
environment interactions.
Mouse models offer a tractable system to interrogate gene–
environment interactions, and mouse models have already been used
to identify genetic loci associated with lung function parameters that
are relevant to asthma. A variety of phenotyping methods have been
used to evaluate airway responsiveness to cholinergic agonists that in-
duce bronchoconstriction and thus cause an increase in resistance to
airflow. Quantitative trait locus (QTL) mapping studies using these
phenotyping methods have identified loci on almost every chromo-
some in the mouse genome (Levitt and Mitzner 1988, 1989; De Sanctis
et al. 1995, 1999; Ewart et al. 1996, 2000; Zhang et al. 1999; McIntire
et al. 2001; Camateros et al. 2010; Leme et al. 2010). These results
suggest that due to the use of different phenotyping approaches these
studies have examined distinct phenotypes (Berndt et al. 2011) and/or
that airway resistance is truly a complex trait with contributions from
many loci. It is important to note that by and large these studies have
used only classical inbred strains or derivatives thereof. Additionally,
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only three studies (Zhang et al. 1999; Ewart et al. 2000; McIntire et al.
2001) have examined airway phenotypes in the context of allergen-
induced inflammation and thereby directly considered the possibility
of gene–environment interactions.
To address the role of gene–environment interactions, we de-
veloped a house dust mite (HDM) model of allergic airway disease
(AAD) (Kelada et al. 2011) and applied this model to incipient
lines of the Collaborative Cross (CC). The CC is composed of a
panel of recombinant inbred lines derived from eight-way crosses
using five classical inbred strains (C57BL/6J, 129S1/SvImJ, A/J,
NOD/ShiLtJ, and NZO/HlLtJ) and three wild-derived inbred strains
(WSB/EiJ, PWK/PhJ, and CAST/EiJ) (Consortium 2012) whose ge-
nomes have recently been sequenced (Keane et al. 2011; Yalcin et al.
2011). Using incipient CC lines, which we refer to as “preCC” mice,
we have identified QTL for relevant AAD phenotypes including
eosinophilic (chr 11) (Kelada et al. 2014) and neutrophilic (Chrs
2,4,7) (Rutledge et al. 2014) inflammation, as well as gene expression
in the lung (i.e., eQTL) (Kelada et al. 2014).
Here we report on one feature of the physiologic response to HDM,
namely bronchoconstrictor (methacholine) response as measured by
whole body plethysmography (WBP). To evaluate the effect of HDM
treatment in preCCmice (which were not inbred/clonal), we employed
a longitudinal study design in which mice were phenotyped using
WBP both before and after HDM treatment, allowing us to distinguish
between methacholine response phenotypes attributable solely to ge-
notype vs. genotype and HDM treatment. To examine CC founder
strains in matched conditions, we used the same longitudinal study
with multiple replicates per strain. We do not argue that the WBP
parameter we examined, enhanced pause (Penh), represents airflow
resistance per se, but rather employed plethysmography as a screening
approach with the intent of subsequently validating results using in-
vasive measurements of airflow resistance.
As expected based on prior studies (Zhang et al. 1997; Brewer et al.
1999; Whitehead et al. 2003; Van Hove et al. 2009; Leme et al. 2010;
Kelada et al. 2011, 2014), we detected significant variation due to both
strain and HDM treatment. We found that distinct loci regulate base-
line (chromosome (Chr) 18) and post-HDM (Chr 19) methacholine
responsiveness and that post-HDM methacholine responsiveness was
correlated with other biomarkers of AAD. Finally, we evaluated
whether the post-HDM methacholine responsiveness QTL had an ef-
fect on lung resistance in an independent set of experiments using
HDM challenged C57BL/6J mice and a consomic strain.
MATERIALS AND METHODS
Mice
We obtained 153 male preCC mice (ages 10–14 wk) from Oak Ridge
National Laboratory (Chesler et al. 2008; Kelada et al. 2012, 2014;
Rutledge et al. 2014). Each mouse was from an independent CC line that
had undergone five to fourteen generations of inbreeding. For each of the
eight CC founder strains, we obtained five to nine mice per strain. All
mice were singly housed, with alpha-dri bedding, in the same facil-
ity under normal 12-hr light/dark cycles. Inbred strains, including
C57BL/6J-Chr19A/NaJ were obtained from the Jackson Laboratory and
were also singly housed tomimic preCCmice. All experiments withmice
were conducted at a facility accredited by the Association for Assessment
and Accreditation of Laboratory Animal Care and the protocol was
approved by an institutional animal care and use committee protocol.
Phenotyping protocol
The study design is shown in Figure 1 and all preCC and CC founder
phenotype WBP data are provided in Supplemental Material, File S1.
For these studies, we adapted an established protocol that produces
hallmark features of AAD (Kelada et al. 2011). Since each preCCmouse
was unique (i.e., not yet fully inbred), we chose to evaluate effect of
allergic inflammation on airway responsiveness to methacholine using
a longitudinal study design in which WBP measurements were made
before and after the induction of AAD by sensitization and challenge
with HDM allergen. We note that longitudinal studies using plethys-
mography have been used before to evaluate changes in airway respon-
siveness to methacholine due to allergic inflammation (Lofgren et al.
2006). On day 1, dose–response measurements using methacholine
(0, 3.1, 6.2, 12.5, and 25 mg/ml) were made (Figure 1). One week later,
the same measurements were made to examine reproducibility, though
in a minority of cases this was not feasible (n = 34 preCC mice). Mice
were then sensitized with 10 mg (in 100 ml) of the immunodominant
allergen from the Dermatophagoides pteronyssinus species of HDM,
Der p 1 (Indoor Biotechnology, Cat. No. LNT-DP1-1), administered
by intraperitoneal injection on days 11 and 18 of the protocol. On day
25, mice were challenged with 50mg of Der p 1 (in 40ml), administered
by oro-pharyngeal aspiration. Mice were phenotyped by WBP for a
final time on day 28. Immediately after the last WBP measurement,
mice were sacrificed by an overdose of pentobarbitol, followed by col-
lection of blood, whole lung lavage fluid, and lung tissue. During the
course ofWBP data collection, somemice exhibited responses tometh-
acholine that necessitated removal from the WBP chamber prior to a
subsequent (higher) dose of methacholine to prevent respiratory diffi-
culty. The decision to remove the mouse from the WBP chamber was
based on visual observation of the mouse and not on a particular
threshold value of Penh because we found that some mice exhibited
signs of respiratory difficulty at lower values of Penh compared to
others. Removal of a mouse from the WBP chamber led to incomplete
dose–response data. However, even with the truncated dose–response
data, we were able to generate an overall phenotype of methacholine
responsiveness that was used for QTL mapping, as described below.
WBP data analysis
The analysis ofWBPdatawas focused on the derived parameter (Penh).
The two baseline measurements of Penh were found to be reproducible
on amouse-by-mouse basis, as shown in Figure S1. As such, the two sets
of baseline WBP data were averaged together to create a mean value of
Penh per dose of methacholine. For mice for which only one baseline
measurement was available, the single measurement was used as the
mean. We then used a simple modeling approach that is analogous to
what is used in human studies wheremethacholine dose–response data
Figure 1 Study design featuring longitudinal WBP
measurements.
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are used to estimate the dose required to elicit a 20% reduction in forced
expiratory volume in the first second. First, for eachmouse, the value of
Penh per methacholine dose was converted to a percent control value,
i.e., the ratio of Penh at a given dose of methacholine compared to Penh
whenmethacholine equals 0, multiplied by 100.We then fit a quadratic
model to the data (on a mouse-by-mouse basis):
Penhð%  controlÞ ¼ aþ b1ðMChÞ þ b2

MCh2
þ error
where MCh = methacholine (mg/ml). Example quadratic model
results are shown in Figure S2. The quadratic model was used to
calculate the dose of methacholine required to produce a 50% increase
in baseline Penh, which we refer to as the provocative concentration
150 (PC150). In addition to mimicking the modeling approach in
humans, this approach also allowed for the calculation of a phenotype
value (PC150) for mice for which we had incomplete methacholine
dose–response data. This is because mice that were removed from the
WBP chambers prior to completing the full dose–response assess-
ment tended to be very responsive to methacholine, and thus inter-
polating a value that produced a 50% increase in Penh (% control) was
feasible.We note that the threshold we used, namely a 50% increase, is
considered a reasonable value (Walker et al. 2013) but could be in-
creased to achieve wider phenotype distributions but this comes at a
cost of not being able to calculate a phenotype value (e.g., PC200) for
mice that never exhibited a doubling of Penh during themethacholine
dose–response (see Figure S2). For one subject (OR3584m51), qua-
dratic model fit was poor and necessitated use of a linear model to
interpolate a value of PC150. Removing this subject from analyses did
not materially change the results obtained. Additionally, seven preCC
mice were almost completely unresponsive to methacholine, preclud-
ing identification of a PC150 value; these mice were therefore removed
from the analyses, resulting in 146 preCC mice with complete phe-
notype data. These data are provided in File S2.
PC150 values for each mouse were calculated for before and after
HDM treatment, and we refer to these as “baseline PC150” and “final
PC150”, respectively, and we calculated the change in PC150 due to
allergen (“delta PC150”) as baseline PC150–final PC150. For most mice,
delta PC150 is positive because of heightened responsiveness to meth-
acholine due to HDM treatment. One mouse showed a large, negative
value of delta PC150 but inspection of the original Penh data for this
mouse did not reveal any obvious abnormalities in the data, so we kept
the mouse in the analysis. All PC150 values for preCC mice and CC
founders are given in File S2. Box Cox transformation analyses indi-
cated that log transformations of baseline and final PC150 were suitable
for subsequent analyses (we used natural log (ln) transformations),
while delta PC150 was left untransformed.
Lung resistance data
We conducted invasive measurements of total lung resistance in two
inbred strains of contrasting haplotypes on chromosome 19, C57BL/6J
and C57BL/6J-Chr19A/NaJ, using the FinePointe Resistance and Com-
pliance instrument from Data Sciences International. After allergen
Figure 2 Baseline (black) and Final (green) Penh among CC founder strains. Data from (A) A/J, (B) C57BL/6J, (C) 129S1/SvImJ, (D) NOD/ShiLtJ, (E)
NZO/H1LtJ, (F) CAST/EiJ, (G) PWK/PhJ, and (H) WSB/EiJ strains, with n = 5-9 male mice per strain. Mean and standard errors are shown. Note that
mice from the A/J, 129S1/SvImJ, and NZO/H1LtJ strains exhibited initial signs of difficulty breathing at 12.5 mg/ml methacholine, so we did not
administer the next dose of methacholine (25 mg/ml) to those mice and thus there are no Penh data for those strains at the highest dose.
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sensitization and challenge as above, mice were anesthetized with ure-
thane (2 g/kg), and then administered pancuronium bromide
(0.8 mg/kg) to prevent voluntary breathing once connected to the
instrument. After a 5 min period of acclimation, increasing doses of
methacholine (0, 6.25, 12.5, and 25 mg/ml) were administered via a
nebulizer for 10 sec followed by measurements of resistance every
2 sec for 3 min. Lung resistance (RL) values for every measurement
cycle over the 3 min recording period are reported PC150 values were
calculated for each mouse as described above after collapsing the
resistance data to mean values of resistance per dose of methacholine.
Genotyping and QTL mapping
Genotypes for all of the preCC mice used in these experiments have
been previously reported (Rutledge et al. 2014). We genotyped each
mouse at the University of North Carolina – Chapel Hill, using one
of two Affymetrix SNP arrays (A or B) that were produced in de-
velopment of the Mouse Diversity array (MDA) (Yang et al. 2009).
After removing uninformative and poorly performing SNPs, these
arrays contained 181,752 (A-array) and 180,976 (B-array) SNP as-
says, and the set of SNPs on each array did not overlap. Most mice
(83%) were genotyped on the B-array and the remaining were gen-
otyped on the A-array. These training arrays were annotated to
NCBI Build 36 of the mouse genome, but we mapped QTL bound-
aries to Build 37 positions to integrate with other resources. We
report NCBI Build 37 positions in our results. We estimated the
most probable ancestor for each SNP in each mouse using the GAIN
algorithm (Liu et al. 2010), and reconstructed founder haplotypes
based on these results. We then merged the nonoverlapping SNP
datasets from arrays A and B by imputing unobserved genotypes
based on inferred founder haplotype, resulting in 360,000 SNP
markers in total. For QTL mapping, we used HAPPY (Mott et al.
2000) to infer ancestry matrices for an additive genetic model. For
efficiency, we then averaged the matrices across SNPs between
which GAIN inferred no recombination in the population, and this
reduced the mapping dataset to 27,059 intervals with an average
spacing of 95 kilobases. We used BAGPIPE (Valdar et al. 2006) to
fit a regression model for log-transformed PC150 and report LOD
scores. Significance thresholds were determined by permutation
(n = 10,000). We used the 1.5 LOD drop method to approximate
confidence intervals for QTL (Dupuis and Siegmund 1999). The
percent of phenotypic variation explained by each QTL was esti-
mated by regression of phenotypes on haplotype probabilities at the
peak locus.
Data availability
Supporting information is provided in two files. File S1 (FileS1_
phenodata_penh.xls) contains Penh data for each mouse used in the
study. File S2 (FileS2_phenodata2_pc150.xls) contains PC150 values
calculated for each mouse in the study. Genotype data are publically
available at http://www.genetics.org/content/198/2/735.supplemental.
RESULTS
The longitudinal study design used is shown in Figure 1. Two baseline
WBP measurements were made, followed by sensitization and chal-
lenge with the HDM allergen Der p 1 over the course of 25 d. At the
study conclusion 3 d later, a final WBP measurement was made fol-
lowed by lung lavage and lung tissue collection. Five to nine mice from
each CC founder strain and 146 male preCC mice were phenotyped in
this manner. Baseline and final Penh values for each CC founder strain
are shown in Figure 2. As expected based on previous findings (Levitt
andMitzner 1988; Duguet et al. 2000), the A/J strain showed the largest
increases in Penh at low doses of methacholine, though WSB/EiJ mice
exhibited remarkably high Penh values at high doses of methacholine.
We employed the same protocol with preCCmice, and we note that
repeatedmeasures of baselinePenhvalues separatedby1wkwerehighly
reproducible on amouse-by-mouse basis, as shown inFigureS1.Aswith
other AAD phenotypes (Kelada et al. 2014; Rutledge et al. 2014), there
was considerable variation in Penh values among preCCmice. For both
Figure 3 PC150 phenotype distributions among CC founder strains
and preCC mice. Log-transformed values are shown for baseline
PC150 (A), final PC150 (B), delta PC150 (C). n = 146 preCC mice. ANOVA
P-values for differences among CC founder strains are 8.9 · 1025,
1.19 · 1025, and 0.33 for baseline PC150, final PC150, and delta
PC150 respectively. For delta PC150, the population mean among
preCC mice is 20.7 mg/ml.
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preCCmice and CC founder strains, we modeled the data as percent of
Penh at baseline using a quadratic function to estimate the dose of
methacholine required to produce a 50% increase in Penh, which we
refer to as PC150, thus condensing the dose–response data into a single
phenotype value. Example methacholine dose–response curves and
quadratic model fitting for preCC mice are shown in Figure S1 and
Figure S2. Overall, there were significant differences in baseline PC150
among CC founder strains (Figure 3A, ANOVA test P-value = 2.4 ·
1024). Importantly, the range of baseline PC150 values among preCC
mice, which spanned two orders ofmagnitude (0.6mg/ml to 20.3mg/ml),
was considerably greater than what we observed for CC founder strains
(range = 1.1–10.8 mg/ml).
WBP measurements conducted after allergen sensitization and
challenge likewise revealed awide rangeof responsesamongCCfounder
strains and preCC mice (Figure 3B). Among CC founder strains, all
strains except CAST/EiJ exhibited significant changes in PC150 due to
the induction of AAD (Table 1 and Figure 2F). The global difference in
final PC150 among founder strains was alsomore statistically significant
compared to baseline PC150 (ANOVA P-value 6.2 · 1027), and we note
in particular that the differences between the two strains with the most
extreme baseline PC150 values, A/J andC57BL/6J, were heightened due
to AAD (i.e., differences in mean final PC150 were greater than differ-
ences in baseline PC150). As with baseline PC150, the range of variation
in final PC150 among preCCmice was greater than among CC founders
(Figure 3B). Overall, allergen sensitization and challenge produced a
significant change in PC150 at the population level among preCC mice
(1.7 mg/ml change, P , 1x1024).
For eachmouse,we thencalculated the change inPC150 (deltaPC150)
as baseline PC150–final PC150. For most preCC mice, delta PC150 is
positive due to the effect of allergic inflammation on methacholine
responsiveness, but some preCCmice exhibited decreases in PC150 after
allergen sensitization and challenge (e.g., Figure S3R), so delta PC150 is
negative. Obtaining negative values of delta PC150 was not surprising
given that two CC founder strains, C57BL/6J and PWK/PhJ, both
exhibited decreased responses to higher doses of methacholine due to
allergen sensitization and challenge (Table 1 and Figure 2, B andG) and
we have previously documented decreased airway resistance due to
allergen in C57BL/6J mice (Kelada et al. 2011). Differences in delta
PC150 among CC founder strains were significant (ANOVA P-value =
0.04), but were not as robust as differences for baseline or final PC150.
Notably, NOD/ShiLtJ mice exhibited the largest change in PC150 due to
allergen with a 3.1 mg/ml difference in PC150, which equates to a 61%
change.
Prior to QTL mapping, we examined other biological correlates of
final PC150 and delta PC150. Specifically, we calculated pairwise corre-
lations between final PC150 and delta PC150 with metrics of airway
inflammation (Kelada et al. 2014; Rutledge et al. 2014) as well as base-
line PC150 (Table 2). By far the strongest predictor of final PC150 was
baseline PC150 (see also Figure S4). Final PC150 was also significantly
correlated with eosinophil and lymphocyte counts, as well as concen-
trations of cytokines in lung lavage fluid, most prominently IL-5 and
IL-10, and to a lesser extent IL-4 and IL-13. Surprisingly, delta PC150
was not correlated with metrics of inflammation; however delta PC150
was strongly correlated with baseline PC150.
We thenperformedQTLmappingusing log (ln)-transformedvalues
of baseline PC150 and final PC150, and untransformed values of delta
PC150. Genome scans are shown in Figure 4 and a summary of QTL
detected is presented in Table 3. We identified one significant and one
suggestive QTL for baseline PC150 on chromosomes (Chr) 18 and 14,
respectively. The allele effects for the Chr 18 QTL are shown in Figure
S5. For final PC150, we identified one significant and one suggestive
QTL onChr 19 and 13, respectively; but we did not detect QTL for delta
PC150. Chromosome region plots of the two significant QTL on Chrs
18 (baseline PC150) and 19 (final PC150) are shown in Figure S6 and
n Table 1 Baseline, final and delta PC150 values for CC founder strains and preCC mice
PC150 (SE) in mg/ml Comparison of Baseline vs. Final
Strain Baseline Final Delta t-statistic d.f. P-value
A/J 2.09 (0.32) 0.75 (0.11) 1.35 (0.39) 4.59 5 5.9 · 1023
C57BL/6J 5.98 (1.13) 7.04 (1.10) 21.06 (1.49) 4.72 5 5.2 · 1023
129S1/SvImJ 4.44 (1.24) 2.97 (1.03) 1.47 (1.50) 3.46 4 3.0 · 1022
NOD/ShiLtJ 5.05 (0.49) 1.96 (0.45) 3.09 (0.45) 13.62 7 ,1 · 1024
NZO/H1LtJ 3.13 (0.39) 2.25 (0.42) 0.87 (0.69) 4.40 5 7.0 · 1024
CAST/EiJ 2.24 (0.42) 2.48 (0.67) 20.24 (0.65) 1.96 4 0.12
PWK/PhJ 3.70 (0.56) 3.96 (0.71) 20.26 (1.05) 3.26 7 1.4 · 1024
WSB/EiJ 4.94 (0.30) 2.97 (0.54) 1.97 (0.78) 8.05 5 5.0 · 1024
preCC 4.87 (0.30) 3.19 (0.24) 1.67 (0.27) 21.19 150 ,1 · 1024
d.f., degrees of freedom.
n Table 2 Correlations between final and delta PC150 values with
markers of inflammationa
Final PC150 delta PC150
Baseline PC150 0.58b 20.61b
Final PC150 1 0.16g
Neutrophils 0.10 20.04
Eosinophils 0.30e 0.03
Macrophages 0.10 20.03
Lymphocytes 0.34d 0.04
IL-4 0.23f 0.00
IL-5 0.37c 20.08
IL-6 0.26f 20.05
IL-10 0.41b 20.03
IL-13 0.26f 20.01
MCP1 0.29e 20.15
CCL11 0.15 0.06
CXCL1 0.15 20.10
CXCL10 0.29e 0.02
TIMP1 0.26f 20.02
IgE 0.14 0.00
IgG1 0.05 20.07
a
Spearman rho values for correlations with cell counts and cytokines (also
measured 72 hr after allergen challenge) are shown.
b
P , 1 · 1026.
c
P , 1 · 1025.
d
P , 1 · 1024.
e
P , 1 · 1023.
f
P , 1 · 1022.
g
P , 5 · 1022.
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Figure S7. These two QTL accounted for 20% and 21% of phenotypic
variance, respectively.
The fact thatQTL for baseline and final PC150 differed indicated that
final PC150 is a distinct phenotype from baseline PC150 despite the fact
that two phenotypes are strongly correlated. Additionally, the strong
correlations between final PC150 and concentrations of interleukins
5 and 10 in lung lavage fluid (Table 2) suggest this QTL is associated
with AAD.We focused our subsequent genetic analyses on the QTL for
final PC150 since our primary interest is in the effect of allergen on
airway responsiveness to methacholine.
We examined the allele effects for the Chr 19 QTL (Figure 5). Final
PC150 differed among preCC mice of the different founder haplotypes
(Figure 5A) with C57BL/6J haplotypes associated with largest final
PC150 values. While not the largest difference between haplotypes,
the contrast between C57BL/6J vs. A/J haplotypes was significant and
noteworthy because it is consistent with the overall difference between
the A/J and C57BL/6J founder strains (see Figure 2), suggesting this
locus may explain a portion of the overall phenotypic variance between
these two commonly used inbred strains.
To further examine this, we plotted raw baseline and final Penh
values (vs.methacholine) as a function of most probable founder hap-
lotype for preCCmice homozygous for A/J andC57BL/6J haplotypes at
this locus (Figure 5B). After allergen sensitization and challenge, preCC
mice with A/J founder haplotypes exhibited higher Penh values at low
doses of methacholine, and at higher doses of methacholine several
mice with this haplotype lack Penh data because they were pulled from
the WBP chambers to prevent respiratory difficulty (note that this was
done without knowledge of genotype). Thus both phenotype metrics,
Penh values and PC150, indicate that the A/J haplotype at this locus
confers higher responses to methacholine after allergen sensitization
and challenge. A similar plot containing data from mice with the A/J,
C57BL/6J, or 129S1/SvImJ haplotypes is provided in Figure S8.
To testwhether theChr19A/Jhaplotypeconfers increased resistance
to airflow per se, we conducted invasive measurements of total lung
resistance using male mice from two strains with contrasting Chr
19 haplotypes, C57BL/6J and C57BL/6J-Chr19A/NaJ, the latter coming
from an established panel of consomic strains (Nadeau et al. 2000). We
sensitized and challenged mice from both strains with house dust mite
Figure 4 Genome scans for baseline (A), final (B) and delta (C) PC150 phenotypes. Dashed horizontal lines indicate 95% and 80% significance
thresholds as determined by permutations.
n Table 3 QTL for methacholine responsiveness before and after
allergen
Phenotype Threshold chr LOD Peaka
95% CI
Starta
95% CI
Enda
PC150 baseline 0.2 14 6.14 22.960 21.810 28.728
PC150 baseline 0.05 18 6.95 64.761 63.670 65.295
PC150 final 0.2 13 6.14 23.826 18.322 39.773
PC150 final 0.05 19 7.62 29.639 27.566 31.134
CI, confidence interval.
a
Positions are in megabases.
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allergen and evaluated total lung resistance in response tomethacholine
challenge. As shown in Figure 6, resistance values in response to meth-
acholinewere not demonstrably different between the two strains. After
collapsing the data to mean values of resistance per dose of methacho-
line (Figure S9), we calculated the values of PC150 for each strain and
found that the difference between the two strains was not significant
[0.586 0.51 vs. 1.656 0.57 (mean6 SE) for C57BL/6J and C57BL/6J-
Chr19A/NaJ, respectively, P-value = 0.18]. These data argue against an
appreciable role for the final PC150 QTL on lung resistance.
DISCUSSION
We employed a longitudinal study design in which partially inbred
preCC mice and CC founder strains were phenotyped before and after
the induction of AAD usingWBP so that we could distinguish between
high responses to methacholine due to strain alone vs. strain and aller-
gen. Our results using CC founder strains indicate that the A/J strain is
highly responsive tomethacholine at baseline, corroborating the results
of several previous studies (De Sanctis et al. 1995; Ackerman et al. 2005;
Leme et al. 2010; Berndt et al. 2011; Kanagaratham et al. 2014), and
even more so after allergen sensitization and challenge. Perhaps the
most interesting finding from studies with CC founders was that the
NOD/ShiLtJ strain showed the largest change in methacholine re-
sponse as a function of allergen sensitization and challenge. Few studies
of AAD have used this strain (Araujo et al. 2004; Aumeunier et al.
2010), but our results suggest much could be gained by using this strain
to identify novel, potentially epistatic (Lin et al. 2013), QTL for AAD.
Studieswith thepreCCmice led to fourprimaryconclusions. First, as
with most traits studied to date (Aylor et al. 2011; Kelada et al. 2012,
2014; Rutledge et al. 2014), there is a wider range of methacholine
responses in the preCC population than in the CC founder strains,
both at baseline and after allergen challenge. This result indicates that
the CC breeding design yielded preCC mice with combinations of
alleles that collectively yield more extreme phenotypes. This was par-
ticularly apparent in the case of preCC mice that responded to low
doses of methacholine with high Penh values; in some cases mice had
been removed from WBP chambers to prevent respiratory distress at
doses as low as 6.25 mg/ml. Second, we found that there was a strong,
negative correlation between the change in PC150 values due to allergen
(delta PC150) and baseline PC150 among preCC mice. The mice that
exhibited large changes in PC150 were ones that initially were not very
responsive to methacholine, which is perhaps intuitive. Third, we found
that postallergen PC150 was significantly correlated with concentrations
of cytokines and chemokines known to be related to AAD, such as classic
Figure 5 Allele effects for Chr 19 final PC150 QTL. (A) Final PC150 values vs. most probable founder haplotype for mice. Final PC150 values have
been inverted (21) to facilitate interpretation of the data in part B. Only data for homozygotes are shown (n = 105). (B) Baseline and Final Penh by
founder haplotype for mice with A/J (n = 12) or C57BL/6J (n = 16) founder haplotypes. Penh data acquired at higher methacholine doses are not
shown because six mice with the A/J haplotype exhibited early signs of respiratory difficulty starting at 12.5 mg/ml, necessitating removal from
the WBP chamber. X-axis values (for methacholine) have been slightly shifted to facilitate visualization of the data. An additional plot including
mice with 129S1/SvImJ founder haplotype is shown in Figure S8.
Figure 6 Lung resistance after HDM sensitization and challenge in
C57BL/6J and C57BL/6JChr19|A/J|Na/J mice. Vertical gray lines represent
points at which methacholine was administered, followed by 3 min of
measurements. Black dots and gray bars represent mean and stan-
dard errors, respectively. Thirteen male C57BL/6J mice and nine
C57BL/6JChr19 A/J Na/J mice were phenotyped.
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Th2 interleukins 4, 5, and 13. Fourth, we found that distinct loci regulate
pre- and postallergen responses to methacholine, consistent with the
hypothesis that gene–environment interactions contribute to the allergen
response. The QTL we identified on Chrs 18 and 19 have not been
identified in previous studies in which WBP was used (Camateros
et al. 2010; Berndt et al. 2011). The novelty of these loci is likely attribut-
able to the genetic diversity present in the CC founder strains and the
effective randomization of the founder genomes. The lack of QTL for
delta PC150 was not surprising given that the differences among CC
founder strains were not as robust as we observed for baseline and final
PC150. This may be due to the fact that the delta PC150 phenotype
includes measurement error (or noise) from two serial WBP measure-
ments, not just one.
Despite the fact that postallergen PC150 was significantly correlated
with hallmark biomarkers of AAD (e.g., eosinophils, lymphocytes, IL-5,
and IL-10 in lung lavage fluid), the QTL we identified for postallergen
PC150 on Chr 19 was not validated in subsequent experiments using
invasive measurements of airway mechanics with two strains of con-
trasting haplotypes in the region of interest. There has been consider-
able debate in the literature about whether Penh is reflective of airway
resistance. Indeed a direct comparison of results usingWBP vs. invasive
measurements of resistance in a large set of inbred strains at baseline
did not show concordance between methods (Berndt et al. 2011). Like-
wise, our findings generated using a genetically diverse population of
mice treated to induce AAD, suggest that while Penh is correlated with
inflammation phenotypes, it is not predictive of airway resistance and
therefore should not be used in these types of studies.
While the results fromChr 19 consomicmice argue against the locus
on Chr 19 being a bona fide QTL for airway hyper-responsiveness, we
cannot exclude the possibility that a second locus on Chr 19 had an
effect on the observed phenotypes, obscuring the effect of the locus we
sought to validate. That is, it is possible that an A/J haplotype on
proximal or distal Chr 19 dampens the effect of the QTL at 30 Mb.
The use of the C57BL/6J-Chr19A/NaJ strain precludes an evaluation of
the effect of the Chr19 locus dissociated from other regions on Chr 19.
Use of currently available CC strains would not address this issue either,
as by and large most CC strains with an A/J haplotype at 30Mb on Chr
19 have A/J haplotypes for the vast majority of the chromosome.
Now that inbred CC lines are established, direct comparisons of
airway resistance as a function of strain and allergen treatment can be
conducted,offeringachance foramorerobust investigationof the roleof
gene–allergen interactions in airway resistance. Additionally, results
from these studies will offer an opportunity to compare the genetic
architecture of arguably the most important aspect of allergic airway
inflammation in mouse models and human disease.
ACKNOWLEDGMENTS
We thank Kathryn McFadden and Joseph Thomas for technical assis-
tance. This work was supported in part by the intramural program
of the National Human Genome Research Institute, National Insti-
tutes of Health (NIH) (ZIA-HG200361), by the US Department of
Energy (Office of Biological and Environmental Research), and
by NIH grants U01CA134240, U01CA105417, 1R01ES024965, and
1R01HL122711.
LITERATURE CITED
Ackerman, K. G., H. Huang, H. Grasemann, C. Puma, J. B. Singer et al.,
2005 Interacting genetic loci cause airway hyperresponsiveness. Physiol.
Genomics 21: 105–111.
Araujo, L. M., J. Lefort, M. A. Nahori, S. Diem, R. Zhu et al., 2004 Exacerbated
Th2-mediated airway inflammation and hyperresponsiveness in autoim-
mune diabetes-prone NOD mice: a critical role for CD1d-dependent NKT
cells. Eur. J. Immunol. 34: 327–335.
Aumeunier, A., F. Grela, A. Ramadan, L. P. Van, E. Bardel et al., 2010 Systemic
toll-like receptor stimulation suppresses experimental allergic asthma and
autoimmune diabetes in NOD mice. PLoS One 5(7): e11484.
Aylor, D. L., W. Valdar, W. Foulds-Mathes, R. J. Buus, R. A. Verdugo et al.,
2011 Genetic analysis of complex traits in the emerging collaborative
cross. Genome Res. 21: 1213–1222.
Berndt, A., A. S. Leme, L. K. Williams, R. Von Smith, H. S. Savage et al.,
2011 Comparison of unrestrained plethysmography and forced oscil-
lation for identifying genetic variability of airway responsiveness in in-
bred mice. Physiol. Genomics 43: 1–11.
Bønnelykke, K., R. Sparks, J. Waage, and J. D. Milner, 2015 Genetics of
allergy and allergic sensitization : common variants, rare mutations. Curr.
Opin. Immunol. 36: 115–126.
Brewer, J. P., A. B. Kisselgof, and T. R. Martin, 1999 Genetic variability in
pulmonary physiological, cellular, and antibody responses to antigen in
mice. Am. J. Respir. Crit. Care Med. 160: 1150–1156.
Busse, W. W., and R. F. Lemanske, 2001 Asthma. N. Engl. J. Med. 344: 350–
362.
Camateros, P., R. Marino, A. Fortin, J. Martin, E. Skamene et al.,
2010 Identification of novel chromosomal regions associated with air-
way hyperresponsiveness in recombinant congenic strains of mice.
Mamm. Genome 21: 28–38.
Chesler, E. J., D. R. Miller, L. R. Branstetter, L. D. Galloway, B. L. Jackson
et al., 2008 The Collaborative Cross at Oak Ridge National Laboratory:
developing a powerful resource for systems genetics. Mamm. Genome 19
(6): 382–389.
Collaborative Cross Consortium, 2012 The genome architecture of the
collaborative cross mouse genetic reference population. Genetics 190:
389–401.
De Sanctis, G. T., M. Merchant, D. R. Beier, R. D. Dredge, J. K. Grobholz
et al., 1995 Quantitative locus analysis of airway hyperresponsiveness in
A/J and C57BL/6J mice. Nat. Genet. 11: 150–154.
De Sanctis, G. T., J. B. Singer, A. Jiao, C. N. Yandava, Y. H. Lee et al.,
1999 Quantitative trait locus mapping of airway responsiveness to
chromosomes 6 and 7 in inbred mice. Am. J. Physiol. Lung Cell. Mol.
Physiol. 277: L1118–L1123.
Duguet, A., K. Biyah, E. Minshall, R. Gomes, C.-G. Wang et al.,
2000 Bronchial responsiveness among inbred mouse strains. Role of
airway smooth-muscle shortening velocity. Am. J. Respir. Crit. Care Med.
161: 839–848.
Dupuis, J., and D. Siegmund, 1999 Statistical methods for mapping quan-
titative trait loci from a dense set of markers. Genetics 151: 373–386.
Ewart, S. L., W. Mitzner, D. A. DiSilvestre, D. A. Meyers, and R. C. Levitt,
1996 Airway hyperresponsiveness to acetylcholine: segregation analysis
and evidence for linkage to murine chromosome 6. Am. J. Respir. Cell
Mol. Biol. 14: 487–495.
Ewart, S. L., D. Kuperman, E. Schadt, C. Tankersley, A. Grupe et al.,
2000 Quantitative trait loci controlling allergen-induced airway hy-
perresponsiveness in inbred mice. Am. J. Respir. Cell Mol. Biol. 23:
537–545.
Kanagaratham, C., R. Marino, P. Camateros, J. Ren, D. Houle et al.,
2014 Mapping of a chromosome 12 region associated with airway hy-
perresponsiveness in a recombinant congenic mouse strain and selection
of potential candidate genes by expression and sequence variation anal-
yses. PLoS One 9: e104234.
Keane, T. M., L. Goodstadt, P. Danecek, M. A. White, K. Wong et al.,
2011 Mouse genomic variation and its effect on phenotypes and gene
regulation. Nature 477: 289–294.
Kelada, S. N. P., M. S. Wilson, U. Tavarez, K. Kubalanza, B. Borate et al.,
2011 Strain-dependent genomic factors affect allergen-induced air-
way hyperresponsiveness in mice. Am. J. Respir. Cell Mol. Biol. 45:
817–824.
Kelada, S. N. P., D. L. Aylor, B. C. E. Peck, J. F. Ryan, U. Tavarez et al.,
2012 Genetic analysis of hematological parameters in incipient lines of
the collaborative cross. G3 (Bethesda) 2: 157–165.
2864 | S. N. P. Kelada
Kelada, S. N. P., D. E. Carpenter, D. L. Aylor, P. Chines, H. Rutledge et al.,
2014 Integrative genetic analysis of allergic inflammation in the murine
lung. Am. J. Respir. Cell Mol. Biol. 51: 436–445.
Leme, A., A. Berndt, L. Williams, S.-W. Tsaih, J. Szatkiewicz et al., 2010 A
survey of airway responsiveness in 36 inbred mouse strains facilitates
gene mapping studies and identification of quantitative trait loci. Mol.
Genet. Genomics 283: 317–326.
Levitt, R. C., and W. Mitzner, 1988 Expression of airway hyperreactivity to
acetylcholine as a simple autosomal recessive trait in mice. FASEB J. 2:
2605–2608.
Levitt, R. C., and W. Mitzner, 1989 Autosomal recessive inheritance of
airway hyperreactivity to 5-hydroxytryptamine. J. Appl. Physiol. 67:
1125–1132.
Lin, X., E. E. Hamilton-Williams, D. B. Rainbow, K. M. Hunter, Y. D. Dai
et al., 2013 Genetic interactions among Idd3, Idd5.1, Idd5.2, and Idd5.3
protective loci in the nonobese diabetic mouse model of type 1 diabetes.
J. Immunol. 190: 3109–3120.
Liu, E. Y., Q. Zhang, L. McMillan, F. P.-M. de Villena, and W. Wang,
2010 Efficient genome ancestry inference in complex pedigrees with
inbreeding. Bioinformatics 26: i199–i207.
Lofgren, J. L. S., M. R. Mazan, E. P. Ingenito, K. Lascola, M. Seavey et al.,
2006 Restrained whole body plethysmography for measure of strain-
specific and allergen-induced airway responsiveness in conscious mice.
J. Appl. Physiol. 101: 1495–1505.
Mannino, D. M., D. M. Homa, C. A. Pertowski, A. A. Ashizawa, L. L. Nixon
et al., 1998 Surveillance for asthma–United States, 1960–1995. MMWR
CDC Surveill. Summ. 47: 1–27.
Mannino, D. M., D. M. Homa, L. J. Akinbami, J. E. Moorman, C. Gwynn
et al., 2002 Surveillance for asthma–United States, 1980–1999. MMWR
Surveill. Summ. 51: 1–13.
McIntire, J. J., S. E. Umetsu, O. Akbari, M. Potter, V. K. Kuchroo et al.,
2001 Identification of Tapr (an airway hyperreactivity regulatory locus)
and the linked Tim gene family. Nat. Immunol. 2: 1109–1116.
Moffatt, M. F., I. G. Gut, F. Demenais, D. P. Strachan, E. Bouzigon et al.,
2010 A large-scale, consortium-based genomewide association study of
asthma. N. Engl. J. Med. 363: 1211–1221.
Mott, R., C. J. Talbot, M. G. Turri, A. C. Collins, and J. Flint, 2000 A
method for fine mapping quantitative trait loci in outbred animal stocks.
Proc. Natl. Acad. Sci. USA 97: 12649–12654.
Nadeau, J. H., J. B. Singer, A. Matin, and E. S. Lander, 2000 Analysing
complex genetic traits with chromosome substitution strains. Nat. Genet.
24: 221–225.
Ober, C., and D. Vercelli, 2012 Gene-environment interactions in human
disease: nuisance or opportunity? Trends Genet. 27: 107–115.
Ortiz, R. A., and K. C. Barnes, 2015 Genetics of allergic diseases. Immunol.
Allergy Clin. North Am. 35: 19–44.
Rava, M., L. M. Smit, and R. Nadif, 2015 Gene–environment interactions in
the study of asthma in the postgenomewide association studies era. Curr.
Opin. Allergy Clin. Immunol. 15: 70–78.
Rutledge, H., D. L. Aylor, D. E. Carpenter, B. C. Peck, P. Chines et al.,
2014 Genetic regulation of Zfp30, CXCL1, and neutrophilic inflam-
mation in murine lung. Genetics 198: 735–745.
Valdar, W., L. C. Solberg, D. Gauguier, S. Burnett, P. Klenerman et al.,
2006 Genome-wide genetic association of complex traits in heteroge-
neous stock mice. Nat. Genet. 38: 879–887.
Van Hove, C. L., T. Maes, D. D. Cataldo, M. M. Gueders, E. Palmans et al.,
2009 Comparison of acute inflammatory and chronic structural
asthma-like responses between C57BL/6 and BALB/c mice. Int. Arch.
Allergy Immunol. 149: 195–207.
von Mutius, E., 2009 Gene-environment interactions in asthma. J. Allergy
Clin. Immunol. 123: 3–11.
Walker, J. K. L., M. Kraft, and J. T. Fisher, 2013 Assessment of murine lung
mechanics outcome measures: alignment with those made in asthmatics.
Front. Physiol. 3: 491.
Welter, D., J. MacArthur, J. Morales, T. Burdett, P. Hall et al., 2014 The
NHGRI GWAS Catalog, a curated resource of SNP-trait associations.
Nucleic Acids Res. 42: D1001–D1006.
Whitehead, G. S., J. K. L. Walker, K. G. Berman, W. M. Foster, and D. A.
Schwartz, 2003 Allergen-induced airway disease is mouse strain de-
pendent. Am. J. Physiol. Lung Cell. Mol. Physiol. 285: L32–L42.
Yalcin, B., K. Wong, A. Agam, M. Goodson, T. M. Keane et al.,
2011 Sequence-based characterization of structural variation in the
mouse genome. Nature 477: 326–329.
Yang, H., Y. Ding, L. N. Hutchins, J. Szatkiewicz, T. A. Bell et al., 2009 A
customized and versatile high-density genotyping array for the mouse.
Nat. Methods 6: 663–666.
Zhang, Y., W. J. Lamm, R. K. Albert, E. Y. Chi, W. R. Henderson et al.,
1997 Influence of the route of allergen administration and genetic
background on the murine allergic pulmonary response. Am. J. Respir.
Crit. Care Med. 155: 661–669.
Zhang, Y., J. Lefort, V. Kearsey, J. R. Lapa e Silva, W. O. Cookson et al.,
1999 A genome-wide screen for asthma-associated quantitative trait
loci in a mouse model of allergic asthma. Hum. Mol. Genet. 8: 601–605.
Communicating editor: D. W. Threadgill
Volume 6 September 2016 | Plethysmography QTL in Mice | 2865
